Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Evolving Epidemiology of IBD.

Windsor JW, Kaplan GG.

Curr Gastroenterol Rep. 2019 Jul 23;21(8):40. doi: 10.1007/s11894-019-0705-6. Review.

PMID:
31338613
2.

Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.

Faye AS, Wen T, Ananthakrishnan AN, Lichtiger S, Kaplan GG, Friedman AM, Lawlor G, Wright JD, Attenello FJ, Mack WJ, Lebwohl B.

Clin Gastroenterol Hepatol. 2019 Jul 20. pii: S1542-3565(19)30772-4. doi: 10.1016/j.cgh.2019.07.028. [Epub ahead of print]

PMID:
31336196
3.

The impact of surgical therapies for inflammatory bowel disease on female fertility.

Lee S, Crowe M, Seow CH, Kotze PG, Kaplan GG, Metcalfe A, Ricciuto A, Benchimol EI, Kuenzig ME.

Cochrane Database Syst Rev. 2019 Jul 23;7:CD012711. doi: 10.1002/14651858.CD012711.pub2. Review.

PMID:
31334846
4.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.

Rose KL, Sherman PM, Cooke-Lauder J, Mawani M, Benchimol EI, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S81-S91. doi: 10.1093/jcag/gwy057. Epub 2018 Nov 2.

5.

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.

Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.

6.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.

Nguyen GC, Targownik LE, Singh H, Benchimol EI, Bitton A, Murthy SK, Bernstein CN, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S68-S72. doi: 10.1093/jcag/gwy051. Epub 2018 Nov 2.

7.

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.

8.

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Jones JL, Nguyen GC, Benchimol EI, Bernstein CN, Bitton A, Kaplan GG, Murthy SK, Lee K, Cooke-Lauder J, Otley AR.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S42-S48. doi: 10.1093/jcag/gwy048. Epub 2018 Nov 2.

9.

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Kuenzig ME, Lee L, El-Matary W, Weizman AV, Benchimol EI, Kaplan GG, Nguyen GC, Bernstein CN, Bitton A, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2.

10.

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.

Kuenzig ME, Benchimol EI, Lee L, Targownik LE, Singh H, Kaplan GG, Bernstein CN, Bitton A, Nguyen GC, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.

11.

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.

Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.

12.

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

Benchimol EI, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Siddiq S, Windsor JW, Carroll MW, Coward S, El-Matary W, Griffiths AM, Jones JL, Kuenzig ME, Lee L, Mack DR, Mawani M, Otley AR, Singh H, Targownik LE, Weizman AV, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5. doi: 10.1093/jcag/gwy052. Epub 2018 Nov 2.

13.

Routine Prophylactic Endoscopic Clipping Is Not Efficacious in the Prevention of Delayed Post-Polypectomy Bleeding: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Forbes N, Frehlich L, James MT, Hilsden RJ, Kaplan GG, Wilson TA, Lorenzetti DL, Tate DJ, Bourke MJ, Heitman SJ.

J Can Assoc Gastroenterol. 2019 Aug;2(3):105-117. doi: 10.1093/jcag/gwy033. Epub 2018 Jul 20.

14.

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort Study.

Shim HH, Ma C, Kotze PG, Seow CH, Al-Farhan H, Al-Darmaki AK, Pang JXQ, Fedorak RN, Devlin SM, Dieleman LA, Kaplan GG, Novak KL, Kroeker KI, Halloran BP, Panaccione R.

J Can Assoc Gastroenterol. 2018 Sep;1(3):115-123. doi: 10.1093/jcag/gwy013. Epub 2018 May 10.

15.

Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: a Systematic Review.

Kotze PG, Underwood FE, Damião AOMC, Ferraz JGP, Saad-Hossne R, Toro M, Iade B, Bosques-Padilla F, Teixeira FV, Juliao-Banos F, Simian D, Ghosh S, Panaccione R, Ng SC, Kaplan GG.

Clin Gastroenterol Hepatol. 2019 Jun 25. pii: S1542-3565(19)30668-8. doi: 10.1016/j.cgh.2019.06.030. [Epub ahead of print]

16.

Reduction in surgical stoma rates in Crohn's disease: a population-based time trend analysis.

Ma C, Almutairdi A, Tanyingoh D, Seow CH, Novak KL, Lu C, Panaccione R, Kaplan GG, Kotze PG.

Colorectal Dis. 2019 Jun 17. doi: 10.1111/codi.14731. [Epub ahead of print]

PMID:
31206974
17.

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.

Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD, Singh H, Targownik L, Taljaard M.

Gut. 2019 Jun 12. pii: gutjnl-2019-318440. doi: 10.1136/gutjnl-2019-318440. [Epub ahead of print]

18.

The globalization of inflammatory bowel disease: the incidence and prevalence of inflammatory bowel disease in Brazil.

Quaresma AB, Kaplan GG, Kotze PG.

Curr Opin Gastroenterol. 2019 Apr 9. doi: 10.1097/MOG.0000000000000534. [Epub ahead of print]

PMID:
30973356
19.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Papamichael K, Cheifetz AS, Melmed GY, Irving PM, Vande Casteele N, Kozuch PL, Raffals LE, Baidoo L, Bressler B, Devlin SM, Jones J, Kaplan GG, Sparrow MP, Velayos FS, Ullman T, Siegel CA.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1655-1668.e3. doi: 10.1016/j.cgh.2019.03.037. Epub 2019 Mar 27.

20.

Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation? Reply from authors.

Frolkis AD, Vallerand IA, Patten SB, Kaplan GG.

Gut. 2019 Mar 20. pii: gutjnl-2019-318650. doi: 10.1136/gutjnl-2019-318650. [Epub ahead of print] No abstract available.

PMID:
30894399
21.

The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience.

O'Donnell S, Borowski K, Espin-Garcia O, Milgrom R, Kabakchiev B, Stempak J, Panikkath D, Eksteen B, Xu W, Steinhart AH, Kaplan GG, McGovern DPB, Silverberg MS.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1541-1549. doi: 10.1093/ibd/izz016.

PMID:
30801121
22.

Changing trends in coding for depression among the UK IBD population: reply from authors.

Vallerand I, Frolkis AD, Patten S, Kaplan GG.

Gut. 2019 Feb 21. pii: gutjnl-2019-318405. doi: 10.1136/gutjnl-2019-318405. [Epub ahead of print] No abstract available.

PMID:
30792245
23.

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.

King JA, Underwood FE, Panaccione N, Quan J, Windsor JW, Kotze PG, Ng SC, Ghosh S, Lakatos PL, Jess T, Panaccione R, Seow CH, Ben-Horin S, Burisch J, Colombel JF, Loftus EV Jr, Gearry R, Halfvarson J, Kaplan GG.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):287-295. doi: 10.1016/S2468-1253(19)30013-5. Epub 2019 Feb 12.

PMID:
30765267
24.

Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.

Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG.

Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054. Epub 2019 Feb 25.

PMID:
30688401
25.

Budesonide for the Induction and Maintenance of Remission in Crohn's Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration.

Kuenzig ME, Rezaie A, Kaplan GG, Otley AR, Steinhart AH, Griffiths AM, Benchimol EI, Seow CH.

J Can Assoc Gastroenterol. 2018 Dec;1(4):159-173. doi: 10.1093/jcag/gwy018. Epub 2018 May 24.

26.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.

27.

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium.

Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018.

28.

Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.

Weizman AV, Nguyen GC, Seow CH, Targownik L, Murthy SK, Boland K, Afzal NM, Khanna R, Jones J, Afif W, Halder S, Reinglas J, Fowler S, Huang V, Kaplan GG, Melmed GY.

Inflamm Bowel Dis. 2019 Jan 10;25(2):328-335. doi: 10.1093/ibd/izy333.

PMID:
30346529
29.

Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression.

Frolkis AD, Vallerand IA, Shaheen AA, Lowerison MW, Swain MG, Barnabe C, Patten SB, Kaplan GG.

Gut. 2019 Sep;68(9):1606-1612. doi: 10.1136/gutjnl-2018-317182. Epub 2018 Oct 18.

PMID:
30337374
30.

Experiences of coeliac disease in a changing gluten-free landscape.

King JA, Kaplan GG, Godley J.

J Hum Nutr Diet. 2019 Feb;32(1):72-79. doi: 10.1111/jhn.12597. Epub 2018 Oct 2.

PMID:
30280436
31.

Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.

Kuenzig ME, Bishay K, Leigh R, Kaplan GG, Benchimol EI; Crowdscreen SR Review Team.

Clin Transl Gastroenterol. 2018 Sep 24;9(9):188. doi: 10.1038/s41424-018-0054-z.

32.

Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.

Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, Tanyingoh D, Wei SC, Lin WC, Lin HH, Li J, Bell S, Niewiadomski O, Kamm MA, Zeng Z, Chen M, Hu P, Ong D, Ooi CJ, Ling KL, Miao Y, Miao J, Janaka de Silva H, Niriella M, Aniwan S, Limsrivilai J, Pisespongsa P, Wu K, Yang H, Ng KK, Yu HH, Wang Y, Ouyang Q, Abdullah M, Simadibrata M, Gunawan J, Hilmi I, Lee Goh K, Cao Q, Sheng H, Ong-Go A, Chong VH, Ching JYL, Wu JCY, Chan FKL, Sung JJY.

Am J Gastroenterol. 2019 Jan;114(1):107-115. doi: 10.1038/s41395-018-0233-2.

PMID:
30177785
33.

Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?

Aubin JM, Bressan AK, Grondin SC, Dixon E, MacLean AR, Gregg S, Tang P, Kaplan GG, Martel G, Ball CG.

Can J Surg. 2018 Aug;61(4):251-256.

34.

Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.

Kotze PG, Ma C, Almutairdi A, Al-Darmaki A, Devlin SM, Kaplan GG, Seow CH, Novak KL, Lu C, Ferraz JGP, Stewart MJ, Buresi M, Jijon H, Mathivanan M, Heatherington J, Martin ML, Panaccione R.

Aliment Pharmacol Ther. 2018 Sep;48(6):626-637. doi: 10.1111/apt.14919. Epub 2018 Jul 31.

PMID:
30063077
35.

Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort study.

Kuenzig ME, Sadatsafavi M, Aviña-Zubieta JA, Burne RM, Abrahamowicz M, Beauchamp ME, Kaplan GG, Benchimol EI.

Clin Epidemiol. 2018 Jul 12;10:831-840. doi: 10.2147/CLEP.S156772. eCollection 2018.

36.

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study.

Vallerand IA, Lewinson RT, Frolkis AD, Lowerison MW, Kaplan GG, Swain MG, Bulloch AGM, Patten SB, Barnabe C.

RMD Open. 2018 Jul 11;4(2):e000670. doi: 10.1136/rmdopen-2018-000670. eCollection 2018.

37.

Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis.

Kotze PG, Ma C, Mckenna N, Almutairdi A, Kaplan GG, Raffals LE, Loftus EV Jr, Panaccione R, Lightner AL.

Therap Adv Gastroenterol. 2018 Jun 21;11:1756284818783614. doi: 10.1177/1756284818783614. eCollection 2018.

38.

Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis.

Mosher VAL, Swain MG, Pang JXQ, Kaplan GG, Sharkey KA, MacQueen GM, Goodyear BG.

Clin Transl Gastroenterol. 2018 Jul 6;9(7):169. doi: 10.1038/s41424-018-0038-z.

39.

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.

Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV Jr, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C, Kaplan GG, Burisch J, Colombel JF.

Gastroenterology. 2018 Oct;155(4):1079-1089.e3. doi: 10.1053/j.gastro.2018.06.043. Epub 2018 Jun 27.

PMID:
29958857
40.

Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn's disease.

Laffin MR, Perry T, Park H, Gillevet P, Sikaroodi M, Kaplan GG, Fedorak RN, Kroeker K, Dieleman LA, Dicken B, Madsen KL.

Sci Rep. 2018 Jun 27;8(1):9734. doi: 10.1038/s41598-018-28071-z.

41.

Psoriasis and the risk of foot and ankle tendinopathy or enthesopathy in the absence of psoriatic arthritis: a population-based study.

Lewinson RT, Vallerand IA, Parsons LM, LaMothe JM, Frolkis AD, Lowerison MW, Kaplan GG, Patten SB, Barnabe C.

RMD Open. 2018 May 21;4(1):e000668. doi: 10.1136/rmdopen-2018-000668. eCollection 2018.

42.

Effectiveness, Complications, and Costs of Rheumatoid Arthritis Treatment with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.

Barnabe C, Zheng Y, Ohinmaa A, Crane L, White T, Hemmelgarn B, Kaplan GG, Martin L, Maksymowych WP.

J Rheumatol. 2018 Oct;45(10):1344-1352. doi: 10.3899/jrheum.170779. Epub 2018 Jun 1.

PMID:
29858236
43.

Does breathing polluted air increase the risk of upper gastrointestinal bleeding from peptic ulcer disease?

Kaplan GG.

Lancet Planet Health. 2017 May;1(2):e54-e55. doi: 10.1016/S2542-5196(17)30030-X. Epub 2017 May 5. No abstract available.

44.

One thousand consecutive in-hospital deaths following severe injury: Has the etiology of traumatic inpatient death changed in Canada?

Roberts DJ, Harzan C, Kirkpatrick AW, Dixon E, Grondin SC, McBeth PB, Kaplan GG, Ball CG.

Can J Surg. 2018 Jun;61(3):150-152.

45.

Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?

Aubin JM, Bressan AK, Grondin SC, Dixon E, MacLean AR, Gregg S, Tang P, Kaplan GG, Martel G, Ball CG.

Can J Surg. 2018 Jun 1;61(4):14616. doi: 10.1503/cjs.014616. [Epub ahead of print]

46.

Is depression screening in patients with acne critical?: reply from authors.

Vallerand IA, Lewinson RT, Parsons LM, Lowerison MW, Frolkis AD, Kaplan GG, Barnabe C, Bulloch AGM, Patten SB.

Br J Dermatol. 2018 Jul;179(1):227-228. doi: 10.1111/bjd.16673. Epub 2018 May 27. No abstract available.

PMID:
29654704
47.

Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Gu P, Kuenzig ME, Kaplan GG, Pimentel M, Rezaie A.

Inflamm Bowel Dis. 2018 May 18;24(6):1280-1290. doi: 10.1093/ibd/izx109.

PMID:
29617820
48.

The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.

Shaheen AA, Kaplan GG, Almishri W, Vallerand I, Frolkis AD, Patten S, Swain MG.

PLoS One. 2018 Apr 4;13(4):e0194839. doi: 10.1371/journal.pone.0194839. eCollection 2018.

49.

Pregnant Women with Inflammatory Bowel Disease Are at Increased Risk of Vitamin D Insufficiency: A Cross-Sectional Study.

Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, Panaccione R, Kaplan GG, Seow CH.

J Crohns Colitis. 2018 May 25;12(6):702-709. doi: 10.1093/ecco-jcc/jjy030.

50.

Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Rezaie A, Gu P, Kaplan GG, Pimentel M, Al-Darmaki AK.

Inflamm Bowel Dis. 2018 Apr 23;24(5):1065-1073. doi: 10.1093/ibd/izx095.

PMID:
29529194

Supplemental Content

Loading ...
Support Center